داروپخش

وپخش | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:

داروهای شیمیایی و گیاهی

Market Type:

Stocks

Status:

Authorized

Last Price: 53,660 2.98
Close Price: 53,680

Cash Flow

2026/08/03
Fiscal Year 2026/03/2012 Month
2026/07/09
Fiscal Year 2026/03/2012 Month

Cash Generated from Operations

5.969 Trillion5.686 Trillion

Income Taxes Paid

-12.734 Billion-7.125 Trillion

Net Cash Flow from Operating Activities

5.956 Trillion5.686 Trillion

Proceeds from Sale of Property, Plant and Equipment

-209.25 Billion

Purchases of Property, Plant and Equipment

-9.971 Billion-9.971 Billion

Purchases of Intangible Assets

--123.607 Billion

Proceeds from Sale of Long-Term Investments

104.919 Billion1.041 Trillion

Cash Paid to Acquire Investments in Associates

--455.102 Billion

Cash Paid to Acquire Long-Term Investments

-377.779 Billion-

Cash Received from Income on Other Investments

2.571 Billion35.77 Billion

Net Cash Flow from Investing Activities

-280.26 Billion-9.971 Billion

Net Cash Flow before Financing Activities

5.676 Trillion5.676 Trillion

دریافت های نقدی حاصل از صرف سهام

6.954 Billion-

Proceeds from Sale of Treasury Shares

57.366 Billion64.32 Billion

Purchases of Treasury Shares

-98.423 Billion-98.423 Billion

Cash Received from Borrowings

-123.053 Trillion

Repayments of Borrowings (Principal)

--104.954 Trillion

Interest Paid on Borrowings

--21.331 Trillion

Dividends Paid

-5.696 Trillion-5.696 Trillion

Dividends Paid to Non-Controlling Interests

--5.18 Trillion

Other Cash Flows from Financing Activities

--142.927 Billion

Net Cash Flow from Financing Activities

-5.73 Trillion-5.73 Trillion

Net Increase (Decrease) in Cash

-54.552 Billion-54.552 Billion

Cash at Beginning of Period

60.675 Billion60.675 Billion

Effect of Exchange Rate Changes

-874.434 Billion

Cash at End of Period

6.123 Billion6.123 Billion

Non-Cash Transactions

11.058 Trillion10.957 Trillion